Smithers Avanza Promotes Dr. Ira DuBey to President
GAITHERSBURG, Md.--(BUSINESS WIRE)--May 9, 2019--Smithers Avanza, a contract research organization (CRO) specializing in supporting development of large molecule therapeutics, announced today that it has promoted Ira S. DuBey, Ph.D., to President of Smithers Avanza.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190509005969/en/
Dr. Ira S. DuBey
Dr. DuBey will be responsible for the strategy of the bioanalytical services business as it expands in number of locations, team members, and capabilities. The promotion supports the organization’s commitment to the principles of providing accurate data, on time, with high-touch, to each of our clients as demand for pharmaceutical testing grows.
“Ira’s rich career journey has included top-level leadership, founder, and business-builder roles,” said Michael Hochschwender, President & CEO of The Smithers Group. “He is committed to bringing talented scientists together to build successful teams that will support our clients with the highest level of service.”
Dr. DuBey has over 25 years of senior executive experience managing and building science-based businesses. Prior to joining Smithers Avanza, he served as Vice President and General Manager of Biotechnology Services for Tandem Labs, Director of Immunochemistry Services at Covance Inc., and Department Head Forensic Toxicology at the National Center for Forensic Science. Dr. DuBey holds an M.S. degree in Toxicology from the University of Maryland Graduate School, an M.B.A. from Johns Hopkins University, and a Ph.D. from the Graduate Center of CUNY.
About Smithers Avanza
Smithers Avanza is a contract research organization (CRO) supporting the pharmaceutical industry. Our scientists have expertise in large molecule bioanalysis, assay development, validation and sample analysis at our GLP- and GCP-compliant and CLIA-certified laboratory. Smithers Avanza supports the development of biologics and vaccines from discovery through phase IV, with expertise that includes bioassays and high sensitivity assays.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190509005969/en/
CONTACT: Media Contact:
Hope Aubin, Director of Marketing
+1 (508) 322-5616
KEYWORD: UNITED STATES NORTH AMERICA MARYLAND NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL OTHER HEALTH RESEARCH OTHER SCIENCE SCIENCE GENERAL HEALTH
SOURCE: Smithers Avanza
Copyright Business Wire 2019.
PUB: 05/09/2019 04:39 PM/DISC: 05/09/2019 04:39 PM